{"nct_id":"NCT04016805","title":"Study to Assess the Efficacy and Safety of Ublituximab and Umbralisib in Participants With Chronic Lymphocytic Leukemia (CLL) Currently Treated With Ibrutinib, Acalabrutinib or Venetoclax","status":"TERMINATED","status_verified_date":"2023-07","start_date":"2019-08-05","start_date_type":"ACTUAL","primary_completion_date":"2022-05-22","primary_completion_date_type":"ACTUAL","completion_date":"2022-05-22","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["TGTX"]}